Regeneron's experimental therapy combo effective in untreated cancer patients

Core Insights - Regeneron announced that its experimental cancer combination therapy demonstrated effectiveness, leading to the disappearance of the disease in previously untreated patients with a type of blood cancer during the initial phase of a late-stage trial [1] Company Summary - The company is advancing its experimental cancer combination therapy, which has shown promising results in a late-stage trial [1]